Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Shares Outstanding (Diluted Average) (2016 - 2025)

Harte Hanks (HHS) has disclosed Shares Outstanding (Diluted Average) for 15 consecutive years, with $7.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 1.72% to $7.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $7.4 million, a 1.72% increase, with the full-year FY2024 number at $7.3 million, changed 0.23% from a year prior.
  • Shares Outstanding (Diluted Average) was $7.4 million for Q2 2025 at Harte Hanks, up from $7.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $7.5 million in Q3 2022 to a low of $6.7 million in Q1 2021.
  • A 5-year average of $7.3 million and a median of $7.3 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 11.44% in 2021, then dropped 1.97% in 2023.
  • Harte Hanks' Shares Outstanding (Diluted Average) stood at $7.2 million in 2021, then increased by 3.44% to $7.5 million in 2022, then fell by 1.97% to $7.3 million in 2023, then decreased by 0.23% to $7.3 million in 2024, then increased by 1.22% to $7.4 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Shares Outstanding (Diluted Average) are $7.4 million (Q2 2025), $7.3 million (Q4 2024), and $7.4 million (Q3 2024).